The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 randomized total eradication of metastatic lesions following definitive radiation to the prostate in de novo oligometastatic prostate cancer (TERPs) trial.
 
Zaker Hamid Rana
No Relationships to Disclose
 
Nicole Helie
No Relationships to Disclose
 
Caitlin Eggleston
No Relationships to Disclose
 
Kaysee Baker
No Relationships to Disclose
 
Jason K. Molitoris
No Relationships to Disclose
 
Matthew J. Ferris
No Relationships to Disclose
 
Akshar Patel
No Relationships to Disclose
 
Young Kwok
No Relationships to Disclose
 
Sarah McAvoy
No Relationships to Disclose
 
Dan Kunaprayoon
No Relationships to Disclose
 
Jack J. Hong
No Relationships to Disclose
 
Matthew Deek
No Relationships to Disclose
 
Philip Sutera
Employment - Catalent (I)
Stock and Other Ownership Interests - Catalent (I); Merck; Pfizer
 
Rebecca A Deek
No Relationships to Disclose
 
Soren Bentzen
No Relationships to Disclose
 
Minhaj Siddiqui
No Relationships to Disclose
 
Heather Dorothy Mannuel
No Relationships to Disclose
 
Arif Hussain
Consulting or Advisory Role - AstraZeneca; Bayer; Exelixis; Janssen Oncology; Merck
Research Funding - Bayer (Inst); Calithera Biosciences (Inst); Clovis Oncology (Inst); Constellation Pharmaceuticals (Inst); FORMA Therapeutics (Inst); Infinity Pharmaceuticals (Inst); Merck (Inst); Nektar (Inst); Orion (Inst); Pfizer (Inst); POINT Biopharma (Inst); Progenics (Inst); Roche/Genentech (Inst); Sotio (Inst); Taiho Pharmaceutical (Inst)
 
Phuoc T. Tran
Honoraria - Reflexion Medical
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer Health; Bayer Health; Dendreon; GenomeDx; Janssen; Myovant Sciences; Noxopharm; Reflexion Medical; Reflexion Medical; Regeneron
Research Funding - Astellas Pharma (Inst); Bayer Health (Inst); Reflexion Medical (Inst)
Patents, Royalties, Other Intellectual Property - Compounds and Methods of Use in Ablative Radiotherapy. Patent filed 3/9/2012. PCT/US2012/028475. PCT/WO/2012/122471.
Travel, Accommodations, Expenses - Reflexion Medical
 
Mark V. Mishra
Employment - Orthofix (I)
Stock and Other Ownership Interests - Adverum